ARCHIVES

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

This article is from The Cancer Letter archive.

Vol. 15 No. 20 | May 19, 1989

Download PDF Visit The Full Archive

Related Articles

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

In Brief: NCAB Lacked Courage On Some Special Actions, Amos Says; Pick Reviewers On Ability Only, Scientist Asks

July 30, 1982

Eight Firms Join AACR As Sustaining Members

April 25, 1997

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

Greenwald Says NCI Still Committed To Year 2000 Goals

January 11, 1991

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995